<DOC>
	<DOC>NCT01502215</DOC>
	<brief_summary>Blood transfusion during perioperative period in patients undergoing to major surgery has been associated to several postoperative complications. Particularly in oncologic surgery, red blood cell transfusion has been investigated as a factor of worse outcome and cancer recurrence due to postoperative impairment of cellular immunity. Although red blood cell transfusion has decreased in worldwide clinical practice, this issue still remains a matter of controversy in oncologic surgery. There are no prospective studies comparing outcomes between restrictive or liberal of blood transfusion strategy in oncologic surgery. This study is a prospective and randomized study comparing clinical outcomes between two strategies of transfusion in oncologic surgery - liberal or restrictive</brief_summary>
	<brief_title>Transfusion Requirements in Surgical Oncologic Patient</brief_title>
	<detailed_description />
	<criteria>Patients with cancer after major abdominal surgery requiring postoperative ICU admission Adults patients Age less than 18 year Hematologic Malignances Intensive care unit permanence lower than 24 hours Renal Chronic Failure in Renal Replacement Therapy Karnofsky Status &lt; 50 Previous anemia (hemoglobin lower than 9 g/dL) Previous thrombocytopenia (platelet number lower than 50.000/mm3) Previous known coagulopathy Anticoagulation therapy Those unable to receive blood transfusion Patients who refused participation in the study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2012</verification_date>
</DOC>